Dr. Edward C. Smith, MD
Pediatrics (Pediatrics Physician)
At a glance
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
- Pediatrics Physician primary
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 5 companies reported 35 payments worth $34,803 in total to this clinician.
| Catalyst Pharmaceuticals, Inc. | $34,336 |
|---|---|
| Biogen, Inc. | $222 |
| Novartis Pharmaceuticals Corporation | $137 |
| Sarepta Therapeutics, Inc. | $80.60 |
| Ultragenyx Pharmaceutical Inc. | $26.84 |
| Honoraria | $30,000 |
|---|---|
| Travel and Lodging | $3,841 |
| Food and Beverage | $962 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,600 |
| Catalyst Pharmaceuticals, Inc. Oct 7, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. May 1, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. Dec 1, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. Oct 29, 2025 | Honoraria AGAMREE · NEUROLOGY | $2,400 |
| Catalyst Pharmaceuticals, Inc. Jul 2, 2025 | Honoraria AGAMREE · NEUROLOGY | $900 |
| Catalyst Pharmaceuticals, Inc. Apr 18, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $794 |
| Catalyst Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $676 |
| Catalyst Pharmaceuticals, Inc. Dec 17, 2025 | Honoraria AGAMREE · NEUROLOGY | $600 |
| Catalyst Pharmaceuticals, Inc. Dec 22, 2025 | Honoraria AGAMREE · NEUROLOGY | $600 |
All 21 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Catalyst Pharmaceuticals, Inc. Dec 22, 2025 | Honoraria AGAMREE · NEUROLOGY | $600 |
| Catalyst Pharmaceuticals, Inc. Dec 17, 2025 | Honoraria AGAMREE · NEUROLOGY | $600 |
| Catalyst Pharmaceuticals, Inc. Dec 1, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. Nov 18, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $156 |
| Catalyst Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $676 |
| Catalyst Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $138 |
| Catalyst Pharmaceuticals, Inc. Oct 29, 2025 | Honoraria AGAMREE · NEUROLOGY | $2,400 |
| Catalyst Pharmaceuticals, Inc. Oct 7, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. Sep 30, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $115 |
| Catalyst Pharmaceuticals, Inc. Sep 25, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $458 |
| Catalyst Pharmaceuticals, Inc. Sep 25, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $296 |
| Catalyst Pharmaceuticals, Inc. Jul 2, 2025 | Honoraria AGAMREE · NEUROLOGY | $900 |
| Catalyst Pharmaceuticals, Inc. May 1, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,300 |
| Catalyst Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $198 |
| Catalyst Pharmaceuticals, Inc. Apr 18, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $794 |
| Catalyst Pharmaceuticals, Inc. Apr 18, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $505 |
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Honoraria AGAMREE · NEUROLOGY | $6,600 |
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $354 |
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $84.00 |
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $42.00 |
| Catalyst Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging AGAMREE · NEUROLOGY · travel to HILLSBOROUGH, FL | $24.75 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $357,384 in research payments for these studies, mostly to the institutions running them.
- Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
Ultragenyx Pharmaceutical Inc. · Terminated · NCT06617429 - A phase 1B multicenter openlabel single ascending dose study to evaluate the safety and tolerability of PF06939926 in ambulatory and nonambulatory subjects with duchenne muscular dystrophy
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.